SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back




Title
: Conversations in Primary Care: March 30, 2019
Activity/Course #:
: 03.30.19CPC

Cost:
: Free
Release/Start Date:
: Mar 30 2019
Expiration Date:
: Mar 30 2019
Topics:
: Primary Care Medicine
Target Audience:
: Primary Care Providers
Format:
: Live Virtual Conferences
Estimated Time To Complete CME Activity:
: 7 hours
Credit(s):
: 6.0 AMA PRA Category I Credit(s)
6.0 AANP Contact hour(s) which includes 3.0 pharmacology hour(s)
Hardware/Software Requirements:

There is no registration fee for this CME live virtual conference!

March 30, 2019
Broadcast Live from Ft. Lauderdale, FL
Start Time: 9:00 am EDT

Click Here to View/Print Slides

Program Summary:

Join Dr. Gregg Sherman and Dr. Nicole Swiner, MD and stay on track to fulfill your CME requirements from the comfort of your home. Utilizing an interactive, moderator led format, this program will present discussions with national thought leaders to help you hone your skills in the diagnosis and management of patients you are likely encountering in your practice. You will be able to interact with the faculty real-time to get your questions answered.

Learning Objectives:
At the conclusion of this program, participants should be able to:

  1. Describe the findings from recent trials of PCSK9i hypercholesterolemia treatments on cardiovascular outcomes; Discuss current guidelines and recommendations on the management of hyperlipidemia in high risk patients; Incorporate current data into secondary prevention treatment strategies for patients with the highest cardiovascular risk; Recognize barriers to access for PCSK9 monoclonal antibody therapy and discuss novel strategies to overcome them
  2. Describe the newer concepts in the pathophysiology of asthma and type 2 inflammation, and the implications of biologic therapies in the era of precision medicine; Implement tools for clinical assessment of asthma control and risk factors for poor asthma outcomes with an emphasis of identifying patients that are candidates for biologic therapy; Individualize treatment of patients with moderate-to-severe asthma using available therapies; Discuss the impact of comorbid conditions on asthma control and the evidence-based approach to their treatment
  3. Describe the prevalence and impact of pseudobulbar affect (PBA) among nursing home residents; Outline strategies for the identification of PBA in the nursing home; Review therapeutic options for PBA; Describe special considerations for the management of PBA among nursing home residents
  4. Implement measurement-based tools for assessing and monitoring symptoms in patients with MDD; Individualize treatment of MDD based on patient presentation, symptom profile and side effects; Recognize when switching initial pharmacotherapy is appropriate; Incorporate shared decision-making strategies into the management of patients with MDD
  5. Identify patients at high risk for nonalcoholic fatty liver disease (NAFLD); Distinguish non-alcoholic fatty liver (NAFL) from nonalcoholic steatohepatitis (NASH) and understand how to stage the disease; Implement ongoing evidence based general management of patients with NASH; Describe the available and emerging treatment options for patients with NASH
  6. Review the epidemiology of primary biliary cholangitis (PBC); Describe the pathophysiology of PBC; Recognize how to evaluate a patient for PBC; Discuss the treatment of PBC, including the treatment of extrahepatic manifestations

Agenda*

9:00-9:05 AM

 

Welcome Remarks
Gregg Sherman, MD and Nicole Swiner, MD 

9:05-10:05   Secondary Cardiovascular Risk Reduction: Incorporating Evolving Data to Individualize Care
David Smith, MD
Moderator Gregg Sherman, MD
10:05-10:10   Break
10:10-11:15
  Individualizing Asthma Care: Addressing Type 2 Inflammation
Diego J. Maselli, MD FCCP
Moderator Nicole Swiner, MD
11:15-11:20   Break
11:20-12:20 PM
  Recognizing and Appropriately Managing Pseudobulbar Affect in the Nursing Home Setting
Gustavo Alva, MD
Moderator Gregg Sherman, MD
12:20-12:50

Lunch Break

12:50-1:50
  Case Studies in MDD: Individualizing Care
Andrew Cutler, MD
Moderator Nicole Swiner, MD
1:50-1:55   Break
1:55-2:55
  The Epidemic of NASH: Current and Emerging Management and Treatment Strategies
Kalyan Ram Bhamidimarri, MD, MPH
Moderator Gregg Sherman, MD
2:55-3:00   Break
3:00-4:00
  Identifying Primary Biliary Cholangitis: An Old Condition with New Therapy
Kalyan Ram Bhamidimarri, MD, MPH
Moderator Nicole Swiner, MD
4:00-4:05



Closing Remarks
Nicole Swiner, MD

* Subject to Change


Faculty

Gustavo Alva, MD, DFAPA
Medical Director, ATP Clinical Research
Volunteer Faculty (Assistant Clinical Professor)
Department of Psychiatry
University of California
Riverside, CA

Kalyan Ram Bhamidimarri, MD, MPH
Transplant Hepatologist, University of Miami
Medical Director of Small Bowel & Multi-visceral Transplantation
Miami Transplant Institute
Miami, FL

Andrew J. Cutler, MD
Clinical Professor of Psychiatry
SUNY Upstate Medical University
EVP & CMO
Meridien Research
Bradenton, FL

Diego J. Maselli, MD FCCP
Associate Professor of Medicine
Division of Pulmonary Diseases & Critical Care
University of Texas Health Science Center at San Antonio
Director, Respiratory Care, University Health System
Director, Severe Asthma Program, University Health System
San Antonio, TX

David N. Smith, MD

Clinical Assistant Professor of Medicine
Yale University
Associate Professor of Medicine, Wingate University
Adjunct Professor at UNC Chapel Hill

Charlotte, NC

Moderators

Gregg Sherman, MD

Chief Medical Officer
National Association for Continuing Education
Plantation, FL

Nicole Swiner, MD
Partner of Durham Family Medicine
Adjunct Associate Professor of Family Medicine
UNC-Chapel Hill
Durham, NC

Planning Committee
Sandy Bihlmeyer, M.Ed.
Senior Project Manager
National Association for Continuing Education

Plantation, FL

Michelle Frisch, MPH, CHCP

Vice-President
National Association for Continuing Education

Plantation, FL

Daniela Hiedra
Activity Director
National Association for Continuing Education
Plantation, FL

Joshua F. Kilbridge
President and Creative Director
Kilbridge Associates
San Francisco, CA

Gregg Sherman, MD
Course Director
Chief Medical Officer
National Association for Continuing Education
Plantation, FL

 

Sponsored and Certified By
National Association for Continuing Education & Association of Black Cardiologists, Inc.
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Secondary Cardiovascular Risk Reduction: Incorporating Evolving Data to Individualize Care
The Association of Black Cardiologists, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Association of Black Cardiologists, Inc. designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 6.0 contact hours of continuing education, including 3.0 pharmacology hours.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.
Commercial Support
This activity is supported by an educational grant from Amgen; an educational grant from Avanir Pharmaceuticals; an educational grant from Intercept Pharmaceuticals, Inc.; an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals; an educational grant provided by Sanofi US and Regeneron Pharmaceuticals; an educational grant from Takeda Pharmaceuticals U.S.A., Inc. and Lundbeck.